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Abstract
Background:  In large asexual populations where beneficial mutations may co-occur and
recombination is absent, the fate of beneficial mutations can be significantly affected by competition
(i.e., clonal interference). Theoretical models predict that clonal interference (CI) can slow
adaptation, alter the distribution of fixed beneficial mutations, and affect disease progression by
impacting within-host evolution of pathogens. While phenotypic data support that CI is a significant
determinant of adaptive outcome, genetic data are needed to verify the patterns and to inform
evolutionary models. We adapted replicate populations of the bacteriophage φX174 under two
levels of CaCl2 to create benign and harsh environments. Genomic sequences of multiple individuals
from evolved populations were used to detect competing beneficial mutations.
Results: There were several competing genotypes in most of the populations where CaCl2 was
abundant, but no evidence of CI where CaCl2 was scarce, even though rates of adaptation and
population sizes among the treatments were similar. The sequence data revealed that observed
mutations were limited to a single portion of one gene in the harsh treatment, but spanned a
different and larger region of the genome under the benign treatments, suggesting that there were
more adaptive solutions to the benign treatment.
Conclusion: Beneficial mutations with relatively large selection coefficients can be excluded by CI.
CI may commonly determine the fate of beneficial mutations in large microbial populations, but its
occurrence depends on selective conditions. CI was more frequent in benign selective conditions
possibly due to a greater number of adaptive targets under this treatment. Additionally, the
genomic sequence data showed that selection can target different types and numbers of
phenotypes in environments that differ by only a single continuous variable.
Background
In asexual populations, adaptive evolution is fueled by
novel beneficial mutations that arise and sequentially fix
due to selection. However, not all of these beneficial
mutations may reach fixation; when they co-occur, com-
petition for fixation ensues [1,2]. Those with higher selec-
tion coefficients are more likely to win the competition
resulting in loss of the smaller effect mutations, a phe-
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nomenon called 'clonal interference' [3,4]. A less severe
version of this type of interference, that can decrease the
efficacy of selection in sexual organisms, occurs when a
locus under weak selection is tightly linked to a more
strongly selected locus (i.e., Hill-Robertson Effect; [5,6]).
Both levels of interference can significantly impact adap-
tive outcome by decreasing the rate of adaptation, altering
levels of standing genetic variation, and favoring the evo-
lution of sex [3,7-13]. A better understanding of the effects
of interference on the fate of beneficial mutations is not
only important in advancing our knowledge of evolution-
ary processes; it also has great practical relevance in mon-
itoring and predicting disease progression in hosts with
chronic infections [14].
Theoretical studies of adaptation in large populations of
asexual organisms show that the strength of interference is
positively correlated with population size and mutation
rate because mutations have a higher probability of co-
occurring under these conditions [3,12,13,15,16]. Under
the assumption that the number of available beneficial
mutations is infinite, CI is predicted to: 1) slow the rate of
adaptation by delaying fixation of beneficial mutations,
and 2) result in a larger mean selection coefficient of fixed
beneficial mutations (i.e., mutations with higher selection
coefficients out-compete smaller ones). Kim and Orr [17]
tested whether fixation of beneficial mutations is delayed
when only a finite number of beneficial mutations are
available in a given genome. Their study showed that CI
can have little effect on the speed of adaptation in large
populations when few beneficial mutations are available,
or when the distribution of beneficial mutations has a
high mean and variance. When beneficial mutations are
extremely rare, each mutation may reach fixation before a
competitor arises. Likewise, when selection coefficients
are very different, the transition time (i.e., time it takes a
beneficial mutation to fix once it has occurred) may be so
short that the large effect mutation reaches fixation before
competitors arise. Ultimately, it is the interplay of these
factors, mutation number and transition time, that deter-
mines the level of CI. Thus, our understanding of adapta-
tion in large asexual populations could be improved by
examining how parameters of the distribution of selection
coefficients for beneficial mutations (i.e., overall number,
mean, and variance) influence levels of CI. Manipulating
environmental conditions is a feasible experimental
approach for testing effects of the distribution of benefi-
cial mutations on levels of CI.
A more recent study of adaptation in large asexual popu-
lations distinguishes between a one-by-one fixation
regime under clonal interference and a multiple mutation
regime where competing genotypes may have more than
one mutation [9]. In contrast to the one-by-one model of
clonal interference, which predicts decelerated adaptation
rates and transient levels of genetic variation at large pop-
ulation size (N) and high beneficial mutation rate (µb),
the multiple mutation model predicts that the both the
speed of adaptation and variation in fitness increase loga-
rithmically with N and with µb.
Consistent with predictions from the one-by-one clonal
interference models [3,12,15,16], experimental evolution
studies with E. coli and vesicular stomatitis virus have
shown that adaptation rates plateau, and that higher pop-
ulation fitness is achieved as population sizes and muta-
tion rates increase [4,18-20]. However, since these data
are phenotypic, CI is not the only explanation for the
observed patterns. In larger populations, adaptive muta-
tions will have longer transition times even in the absence
of competitors, and there may be few adaptive mutations
available under some conditions, especially if the first few
mutations that fix leave the population stranded at a low
local fitness peak. More recent studies have provided a
compelling demonstration that competition between
beneficial mutations affects the probability that genotypes
are lost, emphasizing the importance of multiple simulta-
neous mutations in determining adaptive trajectories
[21,22]. Yet another recent study of adaptation in large
yeast populations did not observe that the speed of adap-
tation decreased during adaption under conditions where
multiple mutations were presumed to be pervasive, and
found that variation in fitness was higher at higher Nµb,
supporting the multiple mutation model of adaptation
[9]. These more recent studies have also tested predictions
of the underlying models of adaptation by observing pat-
terns of phenotypic adaptation. None of the empirical
studies have investigated the presence of competing muta-
tions with genomic sequence data, or examined the
number of genotypes that may be competing at any given
time, although Holder and Bull [23] did observe high fre-
quency polymorphisms during experimental evolution of
bacteriophage in the family Microviridae. Examining the
underlying genetics of CI in large populations evolved in
different environments would increase our mechanistic
understanding of adaptation in large microbial popula-
tions and identify the importance of considering multiple
concurrent mutations in models of adaptation.
A direct way to identify CI in experimental evolution is
through genome sequence analysis. Beneficial mutations
must be present simultaneously for CI to affect their fixa-
tion. Populations with mutually exclusive adaptive geno-
types that coexist at relatively high frequencies indicate CI.
The bacteriophage φX174 is useful for identifying CI
through sequence analysis and experimental evolution
because it is small enough that genomic sequence data
can be obtained for multiple individuals at multiple time
points during the evolutionary trajectory [23-29]. Because
each phage produces about 100 infectious progeny per 20BMC Evolutionary Biology 2008, 8:85 http://www.biomedcentral.com/1471-2148/8/85
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minutes, growing populations must be diluted frequently
during long-term propagation. The bottleneck effects
from flask-to-flask transfers are so strong during experi-
mental evolution of φX174 that there is an extremely low
probability that small-effect or neutral mutations will
attain appreciable frequency in the population. When
only a small number of individuals are sampled from a
large phage population, there is likewise an extremely low
probability of sampling an evolved genotype two or more
times unless it has ascended to high frequency. The pres-
ence of multiple high frequency genotypes in a popula-
tion indicates either a selective sweep in progress or CI,
depending on the nature of the differences between geno-
types.
To identify the underlying genetics of CI we evolved large
populations of φX174 and sequenced genomes of isolated
genotypes from mid- and endpoint populations. We
evolved similarly large populations of phage under differ-
ent levels of CaCl2 to create benign versus harsh condi-
tions in order to test effects of environment on the
frequency of CI. We expected that differences in CaCl2
abundance would alter parameters of the distribution of
available beneficial mutations, thus influencing levels of
CI. We assumed that by limiting the same resource to dif-
ferent degrees, selection would target the same trait(s) in
each treatment, but that mutations that could potentially
improve the trait(s) would be proportionately more ben-
eficial in harsher resource conditions. In other words, we
expected that the number of available beneficial muta-
tions (waiting time) would be similar among treatments,
but that the mean selection coefficient of beneficial muta-
tions would be higher in the harsh environment since
these populations would be further from their local fit-
ness optimum. Under these assumptions, we predicted
that CI would be more prevalent under higher resource
levels since the smaller-effect mutations would have
longer transition times, allowing for their co-occurrence.
In contrast to our assumptions, we did not find evidence
of stronger selection in the harsh environment and did
find evidence that there may have been fewer beneficial
mutations available in the harsh environment. Thus,
although our resource treatments did not have the effects
we expected, they did alter the distribution of available
beneficial mutations in a manner that yielded much
needed insight into the effects of environment on the fre-
quency of CI.
Results
Pre-adaptation to control conditions
Growth rate of the lab strain increased dramatically (by
5.5 ± 0.8 population doublings/hr) during the first 35 pas-
sages in experimental conditions, and very little (0.7 ± 0.6
population doublings/hr) during the next 21. At this
point (56 transfers, 27 hours of growth), we sequenced an
isolate and found three novel mutations (C878T,
G2085C, and C2179T). We then continued the adapta-
tion for 49 more transfers (52 hours of growth) and
sequenced another plaque isolate. No additional muta-
tions were found, and thus we concluded that the geno-
type was fully adapted to the control conditions such that
it would not be expected to undergo further adaptive evo-
lution under control conditions. We measured fitness of
this triple mutant at different concentrations of CaCl2 to
determine conditions where fitness was significantly
decreased relative to those used in the pre-adaptation. We
used this genotype as the ancestor (anc) to initiate the first
line in each treatment. When the control line reached the
midpoint of the evolutionary trajectory, we sequenced 10
isolated genotypes and found that all 10 had an addi-
tional mutation, C788T. In an effort to maintain a control
line, we used this genotype (anc788) to initiate the second
and third lines in each treatment before we knew that
other adaptive mutations would be detected in the end-
point population of the first control line. Thus, the second
and third lines are true replicates of each other, while the
first line in each treatment was initiated from a different
ancestor.
Additionally, since the control lines behaved like the
benign treatment, they were treated as such in the analy-
ses.
Adaptation to treatments
To examine potential differences in adaptation among the
treatments with different ancestors we first conducted a
two-factor ANOVA with interaction on the relative fitness
data, where ancestor and treatment were the main effects.
There was a significant difference in adaptation between
the two ancestors (F1,43 = 63.2, P < 0.0001; Fig. 1A), but
no significant effect of treatment (F2,43 = 2.7, P < 0.083) or
the interaction of ancestor and treatment (F2,43 = 0.38, P <
0.69), indicating that fitness increased by similar amounts
among the resource treatments. Since the control and
benign environments were very similar treatments in
terms of both the level of CaCl2 and the starting fitnesses
of the ancestor (Table 1), we pooled these two treatments
to increase power for testing differences in adaptation
between the benign and harsh environments. Adaptation
was not significantly different between the benign and
harsh treatments for anc (t13 = 1.8, P < 0.10). On the other
hand, adaptation of anc788  was marginally different
between the two environments (t17 = 2.1, P < 0.053). This
difference was statistically significant if we analyzed the
data by a nested ANOVA that accounted for potential var-
iation due to the different lines within treatments (Treat-
ment: F1,28 = 4.6, P < 0.043; Line nested in treatment: F4,28
= 1.0, P < 0.41). Overall, the data showed that there was
no significant difference in the amount of adaptation
between the benign and harsh environments for anc, butBMC Evolutionary Biology 2008, 8:85 http://www.biomedcentral.com/1471-2148/8/85
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that the amount of adaptation may have been slightly
higher in the benign environment for anc788 (Fig. 1B).
Due to these differences and the finding that there was no
significant variation from lines within treatments, we ana-
lyzed fitness data from each ancestor separately, but
pooled data for the benign treatments, and data for anc788
lines within each benign and harsh treatment for subse-
quent analyses of adaptation.
Adaptation and selection strength Figure 1
Adaptation and selection strength. (A) Change in fitness for each experimental line. Data are means for five replicate, 
paired fitness assays of the ancestor and the endpoint population of each line in its respective treatment. anc: black lines (all line 
1), anc788: grey lines, solid grey: line 2, dashed grey: line 3, circles: harsh, triangles: benign. (B) Fitness of each ancestor relative 
to endpoint populations (n = 5). Data from benign environments are pooled, as are data from lines 2 and 3 for anc788 (within 
the H and B treatments). Bars are 95% confidence intervals from t-tests of mean differences between the harsh (H) and benign 
(B) treatments for each ancestor. (C) Mean selection coefficient of mutations in endpoint populations (n = 5). Data from 
benign environments are pooled, as are data from lines 2 and 3 for anc788 (within the H and B treatments). Bars are 95% confi-
dence intervals from t-tests of mean differences between the harsh (H) and benign (B) treatments for each ancestor. (D) The 
change in fitness as a proportion of total fitness (n = 5). Data from benign environments are pooled, as are data from lines 2 
and 3 for anc788 (within the H and B treatments). Bars are 95% confidence intervals from t-tests of mean differences between 
the harsh (H) and benign (B) treatments for each ancestor.BMC Evolutionary Biology 2008, 8:85 http://www.biomedcentral.com/1471-2148/8/85
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Selection strength
Selection strength is determined by parameters of the dis-
tribution of beneficial mutations. If the mean selection
coefficient (S) is large, then selection is strong. Thus, to
evaluate differences in selection strength between treat-
ments, we first compared the average selection coefficient
of mutations by dividing the relative fitness by the average
number of mutations per genome, which was weighted by
the frequency of genotypes with each particular number
of mutations (see Methods). This measure takes into
account both the frequency and effect of observed muta-
tions to estimate the average selection coefficient, but
makes the simplifying assumption that mutations have
equal selection coefficients. We found that selection
strength was significantly higher in the harsh environ-
ment for anc (t11 = 7.18, P < 0.0001; Fig. 1C), but that
oppositely, selection strength was stronger in the benign
environment for anc788 (t26 = 2.52, P < 0.018; Fig. 1C).
Another dimension of selection strength is the amount of
fitness gain as a proportion of total fitness. For example, if
two evolved populations each increase in fitness by 2, but
one population has a total fitness of 4 and the other pop-
ulation has a total fitness of 8, then mutations occurring
in the former case cause proportionately more fitness gain
which could indicate stronger selection. Thus, as a second
method of evaluating selection strength, we compared the
proportional fitness gain between the two treatments for
each ancestor. By this measure, selection strength was
again stronger in the harsh environment for anc (t6 = 4.89,
P < 0.0028; Fig. 1D), but was not different between the
two treatments for anc788 (t13 = -0.19, P < 0.86; Fig. 1D).
Overall, there was evidence that selection was strongest
for anc in the harsh environment. However, since only a
single mutation was found for anc in the harsh environ-
ment, it is possible that we observed this pattern by
chance, and thus we did not consider this a strong result.
Nature of the genetic changes
a. Determining which mutations are adaptive
CI is a process concerning adaptive mutations, yet we did
not measure the fitness effects for most of the individual
mutations observed in this experiment. In order to iden-
tify populations undergoing CI, we used sequence data
(Table 2) and evolutionary theory to infer that most, if not
all, of the mutations were adaptive. We note that the bot-
tleneck sizes in our experiment almost completely
excluded mutations with selection coefficients less than
0.1 (Fig. 5 in [30]), suggesting that: 1) our design was
biased towards sampling large-effect mutations, and 2)
neutral mutations had negligible probabilities of rising to
appreciable frequencies. However, in an effort to be con-
servative, we considered whether each mutation showed
other evidence of being adaptive (Table 3). A common cri-
terion for identifying adaptive mutations from sequence
data is parallel evolution [24,26,31]. We found that ten of
the 23 different mutations were observed in multiple lines
in this study, and seven of these ten parallel mutations
were observed in multiple isolates in at least one line, sug-
gesting that they had attained high frequency. Of the two
parallel mutations not observed at high frequency, one
was observed six times in previous studies. Of the 14
mutations observed in only one line in this study, nine
were observed in more than one isolate (i.e., high fre-
quency). Although it is possible that a mutation could




Line No N30 No/N30 Total hrs Total flasks wo we relW S relW/we
Control 1 1.8 × 106 5.7 × 109 0.0003 74.8 147 16.3 20.5 4.1 1.4 0.20
Benign 1 1.6 × 106 6.4 × 109 0.0003 70.8 138 16.3 20.2 3.9 2.1 0.19
Harsh 1 1.0 × 107 5.7 × 109 0.0014 61.4 66 7.5 10.9 3.4 3.4 0.32
anc788
Control 2 2.3 × 106 3.5 × 109 0.0006 87.4 174 18.0 19.7 1.7 0.8 0.086
31 . 3  ×  1 0 6 4.8 × 109 0.0003 63.5 126 19.1 21.2 2.2 1.1 0.10
Benign 2 3.1 × 106 7.9 × 109 0.0004 38.4 76 17.9 19.8 1.9 1.9 0.097
33 . 2  ×  1 0 6 7.5 × 109 0.0004 43 85 18.5 20.9 2.4 1.3 0.11
Harsh 2 2.4 × 107 4.5 × 109 0.005 68.5 119 11.3 12.3 1.0 0.5 0.08
36 . 3  ×  1 0 7 6.5 × 109 0.01 48.3 80 12.2 14.0 1.8 1.0 0.12
Treatment: Control = 2.0 mM CaCl2, Benign = 1.7 mM CaCl2, Harsh = 0.2 mM CaCl2.
No and N30: Mean phage population sizes at the start and end of each flask growth period.
No/N30: Bottleneck size; lower numbers indicate lines where beneficial mutations had higher extinction probabilities from bottlenecks.
wo: Mean fitness of the ancestor in treatment conditions (n = 5).
we: Mean fitness of the endpoint populations in treatment conditions (n = 5).
relW: Mean fitness of the evolved population relative to ancestor (n = 5).
S: Mean selection coefficient; a measure of selection strength.
relW/we: Fitness change as a proportion of total fitness; a measure of selection strength.
"Harsh" treatments are shown in bold.BMC Evolutionary Biology 2008, 8:85 http://www.biomedcentral.com/1471-2148/8/85
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reach high frequency by hitchhiking with a large-effect
beneficial mutation, the substitution dynamics for eight
of these nine high frequency mutations indicate that
hitchhiking does not explain their ascent to high fre-
quency; hitchhiking could not be ruled out for G2973A.
Thus, there is strong evidence that 18 of the 23 different
mutations are adaptive. There are two mutations where
evidence for their adaptive nature is not as strong –
G2973A and C581T (present in one midpoint isolate). In
the case of G2973A, this mutation has been observed pre-
viously under similar conditions (Pepin, K.M., unpub-
lished data), and it is in a codon adjacent to mutation
C2971T, which showed strong evidence of being adaptive
in the current study. Likewise, the mutation C581T was
observed previously under similar conditions (Pepin,
K.M., unpublished data), and it results in a non-synony-
mous substitution that is two amino acids away from one
that occurred independently in two lines of this experi-
ment (protein E, site 7), as well as being two away from a
site known to have a large effect on lysis regulation (pro-
tein E, site 3, [32]). There is no evidence that the remain-
ing four of the 23 mutations were adaptive (Table 3).
Interestingly, neither the adaptive nature of the two muta-
tions where evidence is weaker, nor the adaptive nature of
these four mutations, affects our conclusions regarding
the presence of CI in any replicate.
b. Number of adaptive mutations per treatment
Another parameter of the distribution of beneficial muta-
tions that can affect levels of CI is the overall frequency of
adaptive mutations that are available. If fewer adaptive
mutations are available, then the waiting time is increased
which could decrease levels of CI. To investigate whether
there were differences in the number of mutations availa-
ble under the two environmental treatments, we com-
pared the number of adaptive mutations identified in
populations from the harsh and benign environments by
a Mann-Whitney U-test. For this analysis, we pooled data
from both ancestors since only one population was exam-
ined for anc in the harsh condition, and we excluded
Table 2: Genotypes Identified by Genome Sequencing.
Anc Treatment Line aMidpoint genotypes bTotal aEndpoint genotypes bTotal cCI dAdap mut
anc Control 1 788 10/10 788,1611, 563 5/9 n, Y 5
788,1611, 587 2/9
788,1611, 576 2/9
anc Benign 1 788 2/10 1611 2/10 Y, Y 3
1611 2/10 1611, 563 3/10
878 5/10 1611, 593 5/10
878, 1702 1/10
anc Harsh 1 ND 3129 9/9 --, n 1
anc788 Control 2 ND 181, 1033 8/10 --, y 3
181, 1033, 1216 1/10
181, 1295 1/10
anc788 Control 3 none 1/10 1302 1/10 Y, Y 3
1302 3/10 1302, 587 6/10
1702 1/10 1302, 593 2/10
3340 4/10 1302, 1690 1/10
3340, 581 1/10
anc788 Benign 2 none 5/9 563 8/10 y, y 3
563 2/9 1295 1/10
587 1/9 181 1/10
624 1/9
anc788 Benign 3 ND 563, 2772 8/9 --, n 2
563 1/9
anc788 Harsh 2 ND 3129, 2973 10/10 --, n 2
anc788 Harsh 3 none 2/9 3039 2/10 n, n 2
3039, 1138 1/9 3039, 2971 8/10
3039 6/9
a Numbers indicate nucleotide positions that are different from ancestor; rows list the mutational position(s) for a single genotype. ND = not done; 
Bold = parallel mutations.
b Total number of genotypes over total number of isolates sequenced.
c CI status of mid- and endpoint populations; y means that multiple mutually exclusive genotypes are present (i.e., A versus B, or AB versus AC, but 
NOT A versus AB; the latter condition is simply a selective sweep in progress, not competition between genotypes). Y = strong CI, where multiple 
isolates of competing mutations were observed; y = weak CI, where only one competing isolate was observed.
d Number of adaptive mutations in endpoint populations as determined from criteria in Table 3. Data were used for Mann-Whitney U-test of Ho: 
The number of adaptive mutations sampled in control/benign endpoint populations is similar to the number of adaptive mutations sampled in the 
harsh populations (i.e., adaptive mutations were not sampled from populations with different distributions of adaptive mutations).BMC Evolutionary Biology 2008, 8:85 http://www.biomedcentral.com/1471-2148/8/85
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mutations that showed no evidence of being adaptive.
There were significantly more adaptive mutations in end-
point populations of the control/benign treatments rela-
tive to those in the harsh treatments (U3,6 = 17, P = 0.039;
Tables 2 and 3).
c. Site of mutations
In the benign environment, adaptive mutations identified
in the endpoint populations were between nucleotide
positions 181 to 2772, spanning several genes, and were
classified into four functional groups (Table 4). On the
other hand, mutations observed in the harsh treatment
Table 3: Mutations Identified by Genome Sequencing.
Genome positiona Treatmentb nt change Protein/positionc Amino acid changed Evidence change is adaptivee
181 C, B G T C17, K44 A, C S, F Parallel High frequency Previous (3)
563 C, B C T (D58) - - Parallel High frequency Previous (1)
576 C C T (E3), (D63) - - High frequency Previous (1)
581 C C T E5, (D64) T,- I,- Previous (1)
587 C G T E7, (D66) W, - L, - Parallel High frequency
593 C, B C T E9, (D68) T, - I, - Parallel High frequency Previous (1)
624 B G T D79, E19 E74, A, L S, F None
788 C, B C T (D133) T,- M,- Parallel High frequency Measured
878 B T C J11 C N High frequency
1033 C G T F10 M I High frequency Previous (1)
1138 H C T (F45) - - None
1216 C C T (F71) - - None
1295 C, B A G F98 N D Parallel Previous (6)
1302 C C G F100 T S Parallel Previous (1)
1611 C, B A G F203 H R Parallel High frequency Previous (4) 
Measured
1690 C C T (F229) - - None
1702 C, B T C (F233) - - Parallel Previous (1)
2772 B T C (G126) - - High frequency
2971 H C T H14 A V High frequency Previous (6)
2973 H G A H15 G S High frequency Previous (1)
3039 H G T H37 V L High frequency
3129 H G T H67 A S Parallel High frequency
3340 C A G H137 G D High frequency Previous (4)
a Genome position of nucleotide mutation.
b C = control; B = benign; H = harsh.
c Gene product (indicated by letter) and amino acid position of mutation.
d Effect of the mutation at the amino acid level (from amino acid/to amino acid). Gene product C is involved in DNA replication, D is the external 
scaffolding protein, E is the lysis protein, F is the major capsid protein, G is the minor capsid protein, H is the pilot protein, J is the DNA binding 
protein, and K is of unknown function. Because φX174 has overlapping reading frames, some changes affect more than one protein.
e Evidence that a particular change is adaptive includes: Parallel = occurrence in multiple lines of this study; High frequency = occurrence in multiple 
isolates in a population in this study, indicating the change was at high frequency in the population and that there was no evidence of hitchhiking; 
Previous (#) = occurrence in previous evolution experiments (the number of evolution lineages that the mutation was observed) [24,26-29, and 
unpublished data]; Measured = measurement of fitness effects. None = no independent evidence that the mutation is adaptive. Of the mutations 
considered to be adaptive by the criteria above, hitchhiking could not be ruled out for 2973 and 581. However, both of these mutations have 
occurred previously under very similar experimental conditions and there are additional indicators that these mutations are adaptive: 581 affects an 
amino acid two away from another that is adaptive in this experiment (protein E, site 7 vs E7), and is also two sites away from a site known to have 
a large effect on lysis regulation (E3 [32]). Mutation 2973 at H15 is adjacent to site H14 which showed strong evidence of being adaptive.
Parentheses indicate synonymous substitutions.
Table 4: Frequency of Mutations in Four Genomic Regions.
Mutation site Protein Putative function Control, Benigna Harsha
181 C, K (DNA maturation and accessory proteins) Burst size 2 0
563, 576, 587, 593, 788 D, E (Lysis protein and its regulatory region) Lysis timing 10 0
1033, 1295, 1302, 1611, 2772 F, G (Capsid proteins) Attachment, stability, assembly 7 0
2971, 2973, 3039, 3129 H (Pilot protein) Eclipse rate: DNA ejection into host 0 5
a Numbers are the frequency that mutations from a particular functional category were observed in independent evolution lines under the indicated 
treatments.
Only adaptive mutations (i.e., satisfying criteria in Table 3) from endpoint populations are shown.BMC Evolutionary Biology 2008, 8:85 http://www.biomedcentral.com/1471-2148/8/85
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were all in gene H between positions 2971 and 3129. This
pattern was not absolute. The C788T change at E74 in
anc788  was beneficial in the harsh environment even
though it did not occur there, and A3340G at H137 was at
high frequency in the midpoint of control line 3, but lost
at the end. Nevertheless, it appeared that changes affecting
different viral functions dominated adaptation under
benign and harsh treatments (Tables 3 and 4), and in the
benign environment, a larger number of sites in several
genes was able to contribute adaptive solutions, while in
the harsh environment, solutions appeared to be more
limited.
Frequency of CI
We evaluated the frequency of CI by determining the
number of endpoint populations where CI was present or
absent and comparing these frequencies between treat-
ments by a Fisher Exact Test (see Discussion and Table 3
for criteria used to identify CI; Tables 2 and 5). Again, we
pooled data from both ancestors in order to increase sam-
ple size and considered the control as a benign treatment.
We found that significantly more populations showed evi-
dence of CI in the benign environments relative to the
harsh environment (Table 5).
Another pattern that would support the occurrence of CI
under our experimental conditions is the observation of
mutations in a midpoint population that were not seen in
the endpoint population of the same line. We therefore
examined variation at the midpoint of some populations
where the endpoint strongly indicated CI and in line 3 of
the harsh treatment where variation (but not CI) was
present in the endpoint population. CI was evident in
three of the four midpoint populations from control and
benign treatments, and all three of these had mutations
that were not seen among the endpoint isolates. In two of
these cases, the lost genotypes were at very high frequency
(4/10 and 5/10; Table 2). In the harsh environment, there
was no evidence of CI in the midpoint population, and
although there was one mutation that was not observed in
the endpoint population, that mutation was a synony-
mous mutation with no independent evidence of being
adaptive.
To examine whether mutations that were lost between the
midpoint and endpoint populations could have been out-
competed, we measured the selection coefficients of a
mutation that showed evidence of being lost due to CI,
and of the mutation that may have out-competed it (Fig.
2, Table 2). In the midpoint population of control line 1,
only C788T was detected, while in the midpoint popula-
tion of benign line 1 there were four genotypes, including
C788T. By the endpoints, C788T was present in all geno-
types of control line 1 but was not detected in benign line
1, and A1611G was detected in all genotypes in the end-
point populations of both treatments. Apparently,
A1611G did not interfere with the fixation of C788T in
the control line, but did interfere in the benign line. If CI
were responsible for this outcome, then in the benign
line, both mutations should be adaptive and A1611G
should have a significant advantage over C788T. Indeed,
both mutations had a significant selective advantage over
their ancestor (Fig. 2; benign – A1611G: t4 = 11.7, P =
0.0003; C788T: t4 = 7.4, P = 0.0017), and the A1611G
mutation had a significant selective advantage over the
C788T mutation (t4 = 6.3, P = 0.0032), supporting that
C788T was lost due to CI by A1611G in the benign line.
Frequency of multiple mutations
Evidence supporting the multiple-mutations model ver-
sus the one-by-one model of clonal interference would be
Table 5: Summary of Endpoint Populations Showing Evidence of 
CI.
Endpoint populations Pooledb Ancestors Fisher Exact P <x
Benign
Pops with CIa 5 0.048c
Pops with no CIa 1
Harsh
Pops with CIa 0
Pops with no CIa 3
a Pops with CI: Total number of populations in each treatment (harsh 
versus benign) showing evidence of CI (as determined in Table 2); Pops 
with no CI: Total number of populations not showing evidence of CI.
b Number of endpoint populations with or without evidence of CI 
pooled across both ancestors.
c Ho: The frequency of populations showing CI is not higher in benign 
conditions.
Selection coefficients of two mutations from Line 1 control  and benign treatments Figure 2
Selection coefficients of two mutations from Line 1 
control and benign treatments. Zero indicates fitness of 
the ancestor. Each point is a mean estimated from five paired 
replicate fitness measures. Bars are standard errors of mean 
selection coefficients (circle: C788T; triangle: A1611G).BMC Evolutionary Biology 2008, 8:85 http://www.biomedcentral.com/1471-2148/8/85
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the occurrence of more than one change from the fixed
genotype. We found four populations where a single iso-
late differed from the (putatively) fixed genotype by more
than one change: benign 1 midpoint, isolate 878, 1702;
control 2 endpoint isolate 181, 1033, 1216; control 3
midpoint, isolate 3340, 581; and harsh 3 midpoint, iso-
late 3039, 1138. (The mutation presumed to have
occurred second in an already variable background is indi-
cated in bold.) In two of these cases (1216 and 1138), the
changes were synonymous in gene F and there is no inde-
pendent evidence to suggest that the additional change
was adaptive. In the two cases where there is evidence that
the additional changes were adaptive (1702 and 581),
they were seen only in the midpoint populations. Addi-
tionally, since the control lines behaved like the  benign
treatment, they were treated as such in the analyses.
Discussion
Theoretical models and empirical data show that
increased population sizes and mutation rates can slow
the rate of adaptation and decrease the probability that
beneficial mutations will reach fixation [3,12,18-22]. Phe-
notypic data from the empirical studies show that rates of
adaptation do not increase linearly with population size,
but it is not clear whether this pattern is actually due to
competing mutations or simply because each mutation
will have a longer transition time in larger populations. It
is also not clear how many genotypes might be competing
at any given time, which is an important parameter for
studying properties of adaptation and predicting adaptive
walks. We evolved nine lines of phage and sequenced
genomes of multiple individuals from populations in
these lines to examine the underlying genetics of CI. We
found that mutations with relatively large selection coeffi-
cients can be out-competed and that there were as many
as three competing genotypes in many of the populations
where resource was abundant, even though the regular
strong bottlenecks inherent to our flask-to-flask transfer
protocol strongly decreased our ability to observe most
mutations. This suggested both that beneficial mutations
and CI were remarkably prevalent. Our sequence data did
not reveal any CI in the harsh treatment, which empha-
sized that the frequency of CI can vary among similarly
large populations due to environmental conditions.
Adaptation under different levels of resource
The resource treatments were intended to alter parameters
of the distribution of beneficial mutations in order to
evaluate environmental effects on levels of CI in similarly
large evolving populations. While we found evidence that
there were differences between lines in the available ben-
eficial mutations, these differences were not as we pre-
dicted. We expected that the ancestor would be further
from its fitness optimum under harsh resource condi-
tions, which would result in a larger mean selection coef-
ficient for beneficial mutations. However, there was
insufficient evidence that the mean selection coefficient of
beneficial mutations was higher in the harsh environment
for anc, and it even appeared to be lower in the harsh treat-
ment for anc788. Apparently, the C788T mutation in anc
increased fitness in the harsh environment (Fig. 1A), such
that selection was weaker on anc788 than on anc in the
harsh environment. Also, although we expected that the
variable resource levels would select for improvement on
the same trait, the sequence data suggested that the
stronger selection was on different targets between the
two resource treatments, and possibly more genetic solu-
tions were available in the benign environment. Thus, it
appeared that the distribution of beneficial mutations dif-
fered in overall frequency of adaptive mutations between
the resource treatments, such that more mutations were
available in the benign environment.
Factors affecting the frequency of CI
When considering the overall frequency of CI for both
ancestors, we observed CI in most populations in the
benign environments but not in any populations in the
harsh environments (Tables 2 and 5). While this result
was consistent with our original prediction, it was not
attributed to a larger mean selection coefficient in the
harsh environment as we had predicted. For example,
selection was possibly weaker for anc788 in the harsh envi-
ronment, yet no CI was observed in any of those popula-
tions. Additionally, although we found that the selection
coefficient of the mutation that occurred in the harsh
environment of line 1 was very high, it was the only muta-
tion observed, and thus chance cannot be out-ruled as an
explanation for the difference in selection strength
between the treatments in line 1. However, there was evi-
dence of an overall trend of fewer adaptive mutations in
the harsh condition (Tables 2 and 3), suggesting that the
lower levels of CI in the harsh environment may have
been due to the lower number of available adaptive solu-
tions, which would increase the waiting time for benefi-
cial mutations and decrease their co-occurrence
[3,12,16,17].
Interestingly, even though the frequency of CI appeared to
differ among the two resource treatments, their overall
increase in fitness was similar, as were the population
sizes among experimental lines. This result emphasizes
two important points: 1) that CI does not necessarily
decrease rates of population adaptation, and 2) that levels
of CI are not necessarily predictable from population size.
Regarding adaptation rate, it is indeed possible that CI
acts to increase population adaptation by maintaining
higher levels of genetic variation. For example, if a very
high fitness peak can only be achieved through a specific
ordering of substitutions, delayed fixation time from CI
could increase the probability that primary mutations inBMC Evolutionary Biology 2008, 8:85 http://www.biomedcentral.com/1471-2148/8/85
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the order are maintained long enough for the subsequent
necessary mutations to arise. In the absence of CI, fixation
of alternate mutations may be too rapid, occurring before
the critical primary mutations, which could result in the
population being stranded on a lower fitness peak than
what could have been realized through a different adap-
tive walk. In this manner, the decreased rates of adapta-
tion that are predicted to occur from competing
mutations, could be outweighed by larger final fitness
gains due to the more thorough exploration of sequence
space that occurs in populations undergoing CI. This
could partly explain our observation of similar levels of
adaptation, but different levels of CI, among the two
resource treatments.
There appeared to be fewer adaptive solutions available in
the harsh treatments since fewer different mutations were
observed and most occurred in a single gene. All substitu-
tions in the endpoint populations of the harsh treatment
were in gpH, a capsid protein involved in guiding phage
DNA into host cells [33,34], while those detected in the
control and benign environments occurred in several dif-
ferent genes, including the gene encoding the major cap-
sid protein (gpF), as well as in genomic regions that are
putatively involved in regulation of lysis timing [32]. GpF
is involved in numerous processes throughout the phage
life cycle including attachment to hosts, catalysis of
eclipse, and assembly [35-37]. The apparently larger
number of genetic solutions in the benign environment
relative to in the harsh environment suggested that: 1)
selection acted on a broader range of phenotypes in the
benign treatments, and/or 2) there were more genetic
solutions to the types of phenotypes under selection in
the benign treatments. In the harsh environment where
Ca+2 was very limiting, there should be strong specific
selection on capsid proteins to either be able to inject
DNA with fewer Ca+2 molecules or to become more effi-
cient at acquiring Ca+2 since genome injection is crucial to
initiating infection. In other words, in the harsh environ-
ment, improvement of this trait must come before other
potential renovations to growth rate. In contrast, in the
benign environments where growth rates were already
high at the outset, modification of any phenotype affect-
ing growth rate (i.e., attachment, penetration, replication,
assembly, lysis timing, etc.) could be effective at increas-
ing fitness. For example, one strong source of selection
inherent to all treatments is bottleneck survival. Faster
lysis is a conceivable adaptive response under these condi-
tions: phage genotypes with the highest number of free
phage immediately before transfer (i.e., phage that have
propagated and lysed) will have the highest probability of
being transferred to the next flask, and these genotypes
will go on to initiate the most individual infections in the
subsequent flask. Thus, in the benign conditions adapta-
tion could occur through any modification that produced
a high number of phage by the end of each flask growth
period whereas in the harsh environment selection specif-
ically targeted injection rates before any other process in
the phage life cycle, suggesting that the higher levels of CI
in the benign environment could have been due to a
larger number of adaptive targets under these conditions.
Experimental design issues
a. Bottleneck effects
Since phage had higher growth rates in the benign envi-
ronment, bottlenecks to a smaller population size were
required to maintain population sizes similar to those in
the harsh treatments (Table 1). Thus, beneficial mutations
that arose in the benign condition had a higher probabil-
ity of extinction due to bottlenecks [38], suggesting that
our design was slightly biased towards finding mutations
in the harsh condition. Interestingly, we found fewer
adaptive mutations and lower levels of CI in the harsh
treatment where the extinction probabilities of beneficial
mutations due to bottlenecks were lower. This demon-
strates that the difference in CI between the two treat-
ments may have been even more dramatic (i.e., more
frequent in the benign condition) if bottleneck sizes were
equal. Thus, our approach to testing the hypothesis that
CI would be stronger in benign environments was con-
servative.
b. Growth rate differences
The combined effect of differences in growth rates for
phage in the two treatments and frequent, regular, strong
bottlenecking is an experimental design factor that could
have increased the extinction probability of mutations in
the harsh environment. Previous work has shown that
phage with lower growth rates have increased burst times
[39], suggesting that replication is slower. If the higher
growth rates of phage in the benign environment translate
to faster replication relative to that in the harsh environ-
ment, then mutations would arise earlier in flask growth.
From the work of Wahl and Gerrish [38], we found that
mutations arising in the last five minutes of flask growth
have a greater than 99% chance of being lost due to sam-
pling, regardless of their selection coefficients, while those
arising in the first five minutes are likely to survive the bot-
tleneck if their selection coefficients are high. Thus, the
lower growth rates of phage in the harsh environment
could have increased the extinction probability of benefi-
cial mutations if most were produced too late during flask
growth to survive the bottleneck. If present, this effect
could explain the lower levels of CI observed in the harsh
condition. However, it is also possible that the less severe
bottleneck in the harsh condition, which decreased
extinction probabilities (see previous section), acted to
negate potential effects from low growth rates.BMC Evolutionary Biology 2008, 8:85 http://www.biomedcentral.com/1471-2148/8/85
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Implications of CI for predicting adaptation
In four of the five lines where we sequenced isolates from
the midpoint populations, we found genotypes that were
no longer present in the endpoint population, which we
refer to as 'lost.' Furthermore, from measuring the selec-
tion coefficients of one of these lost individuals we found
that mutations with relatively large selection coefficients
can be lost. These data demonstrated two important
points that are relevant to understanding and predicting
adaptation. First, the probability that a beneficial muta-
tion is lost due to a deterministic evolutionary phenome-
non such as CI depends partly on stochasticity from the
time that other mutations of similar effect arise. In popu-
lations that are subject to strong sampling effects, it is pos-
sible for a small-effect mutation to reach fixation in the
presence of a larger one, as long as the smaller-effect
mutation is near fixation before the larger-effect mutation
arises, such that the larger-effect mutation is more
strongly affected by the stochastic sampling. Second, the
fact that relatively large-effect beneficial mutations were
lost in competition supports the finding that beneficial
mutations may be much more frequent than believed
[40,41]. Many beneficial mutations are often not seen
because they can only be sampled in environments where
selection coefficients are similar among mutations, or
where there are no mutations with very large selection
coefficients. This emphasizes the importance in measur-
ing adaptation in numerous environments in order to
develop predictive models and understand evolutionary
processes.
The co-occurrence of high frequency beneficial mutations
has been previously observed during experimental evolu-
tion of microvirid phages in batch culture (φX174 and G4
phages; [23]). We found evidence for CI in five out of nine
populations even though all mutations had high extinc-
tion probabilities, suggesting that CI can be remarkably
common in large bacteriophage populations. While in
most cases competing genotypes differed from the (puta-
tively) fixed genotype by only by a single adaptive muta-
tion, which supports predictions of the one-by-one model
of clonal interference, we found limited support for the
multiple mutation model. There were four cases where a
single isolate differed from the fixed genotype by more
than one change, although in two of these cases there is
no evidence that the additional change is adaptive. In no
case did these genotypes carrying multiple mutations
dominate in the endpoint populations. Taken together,
our data and the recent study in yeast emphasize that con-
current mutations are an important determinant of adap-
tive trajectories in large microbial populations.
Nevertheless, sequence-based models of adaptation that
assume selection is strong relative to mutation (Strong
Selection Weak Mutation assumption, SSWM), such that
one beneficial mutation is fixed before the next occurs,
have been considered acceptable for describing properties
of adaptive walks in asexual organisms [42-44]. Our
experimental data suggest that SSWM conditions may
often be unrealistic in large microbial populations, and
thus that models of adaptation relying on this assumption
may make misleading predictions regarding the proper-
ties of adaptive walks in large microbial populations.
Models of adaptation that include concurrent mutations
and multiple concurrent mutations on individual geno-
types [3,9] may provide more realistic frameworks for
investigating the properties of adaptation in large micro-
bial populations.
Conclusion
We verified with sequence data that CI occurs in large
virus populations and that several genotypes may co-
occur at very high frequencies. We intended to test the pre-
diction that weak selection in benign environments
would result in more CI on average. While our data
showed that CI was more frequent in benign treatments,
this difference was not attributed to weaker selection. It
appeared that the higher frequency of CI in the control
and benign environments was partly due to a higher
number of potential adaptive solutions in those environ-
ments, relative to that in the harsh treatment, which
would have decreased the waiting time for beneficial
mutations. At the very least, our results showed that envi-
ronmental conditions can alter the frequency of CI among
similarly large populations, which demonstrates that
effects of CI are not necessarily predictable from popula-
tion size. Another important insight from our genetic data
was that selection appeared to target different phenotypes
in treatments where the same continuous resource varia-
ble was decreased to different degrees. Finally, we
observed that the fate of mutations with relatively large
selection coefficients depends on the time that other
large-effect mutations arise, suggesting that these stochas-
tic population-level processes are significant properties of
adaptive landscapes, as predicted by theoretical models.
Methods
Biological system
φX174 is a single-stranded, lytic DNA bacteriophage. Its
genome is 5386 bases and consists of 11 genes [45].
φX174 proliferates rapidly; on average a high fitness phage
produces 100 mature progeny in a single lytic cycle which
takes 20 minutes (generation time). A lipopolysaccharide
(LPS) mutant derivative of E. coli F470 (CGW317), which
produces rough LPS with a full inner and outer core but
no O-antigens, was the host used in all evolutions and fit-
ness assays [46].
Experimental evolution conditions
An isolate of a lab strain of φX174 (GenBank accession
AF176034) was pre-adapted to our experimental condi-BMC Evolutionary Biology 2008, 8:85 http://www.biomedcentral.com/1471-2148/8/85
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tions: serial flask transfers in 20 ml liquid media (10 g/L
tryptone, 5 g/L yeast extract, 10 g/L NaCl, and 2.0 mM
CaCl2) with 30-minute growth periods per flask on E. coli
CGW317. Flasks were shaken in a water bath at 200 rpm
at 38.5°C. To maintain a constant, homogenous environ-
ment and to eliminate coevolution between phage and
hosts, each flask was inoculated with a sample of host
cells from a pre-prepared stock. The stock of hosts had
been amplified as a large batch, harvested during the
exponential growth phase, divided into individual tubes,
and stored at -80°C. Naïve host cells were added to each
flask at a density of 4 × 107 cells/ml (OD600 = 0.05). Flasks
were then incubated for one hour such that cell density
reached 1 × 108 cells/ml (OD600 ≈ 0.13) before the addi-
tion of phage. After each 30-minute flask growth period,
cultures had reached densities of about 4 × 108 cells/ml
(OD600 ≈ 0.5), which is about 8 × 109 total cells. Phage
were inoculated at a multiplicity of infection of 0.005 to
0.1, depending on their growth rates. Each line was initi-
ated from an isolated plaque (clonal population). We
monitored adaptation by measuring numbers of phage at
the start and end of each 30-minute flask growth period
and calculating the population growth rate [39]. Samples
from each flask were stored at 4°C and -20°C. We aimed
to maintain phage populations at lower densities than
hosts to decrease the probability of co-infection and
maintain selection on growth rate. Despite these efforts,
titer data from each flask during the trajectory showed that
some phage populations reached the same size as bacte-
rial populations, suggesting that co-infection could have
occurred at later stages during flask growth in some of the
cells. Since φX174 is thought to be capable of recombina-
tion during co-infection, this suggests that low rates of
recombination were possible [47,48]. However, this was
likely to be rare since phage densities only approached
those of hosts late during flask growth, and each transfer
involved a bottleneck to a smaller population size such
that co-infected hosts would be subject to strong sampling
effects.
Experimental design
We pre-adapted the laboratory strain (above) to our
experimental conditions in order to obtain a starting gen-
otype that was very near a local fitness optimum. The pre-
adapted genotype was then evolved further under differ-
ent levels of CaCl2, a resource that is important for attach-
ment and required for catalyzing a conformational change
in phage capsid proteins, which results in injection of the
phage genome into its host [35,37,49]. Our CaCl2 treat-
ments were: 1) identical to pre-adaptation conditions
(control), 2) slightly lower CaCl2  concentration with
undetectable differences in phage growth rate (benign),
and 3) much lower CaCl2 concentration with significantly
lower phage growth rate (harsh). This design was expected
to expose the ancestral genotype to different parameters of
the distribution of available beneficial mutations by
changing its proximity to a local fitness optimum. Experi-
mental parameters for each line are shown in Table 1.
Each experimental line was evolved until the sum of
phage offspring from all flasks in the line (i.e., the cumu-
lative number of progeny produced) was equal to 6 ×
1011. Midpoint populations were sampled at 3 × 1011 total
genomes. We chose total new genomes as our measure of
evolutionary time instead of the usual measure, genera-
tion time, in order to allow for equal numbers of muta-
tions in each resource treatment. In these phage,
generation time is equivalent to a full lytic cycle, and burst
size can be much higher for phage with high growth rates
relative to those with low growth rates. Thus, the opportu-
nity for mutations to arise, and for clonal interference to
occur, would differ between phage in benign and harsh
environments if we used generation time as our measure
of evolutionary time. Under the simplifying assumption
that all mutations are equally likely, 6 × 1011 total progeny
means that every possible mutation could have occurred
1.7 × 105 times according to the following rationale. The
total number of genomes (6 × 1011) multiplied by the
mutation rate in number of mutations per genome per
replication (0.0046; [50]) gives the total number of muta-
tions (2.8 × 109). Since there are 5386 sites in the genome
and three possible mutations per site, the number of pos-
sible mutations in the genome is 5386 × 3 = 1.6 × 104. The
total number of mutations that occurred (2.8 × 109)
divided by the total number of possible mutations (1.6 ×
104) gives the average number of times each possible
mutation occurred at each site, which is 1.7 × 105. This is
a rough estimate due to transition/transversion bias,
among-site rate variation, and strong bottleneck effects
from the flask-to-flask transfer regime. However, it does
suggest that all mutations should have arisen many times
during our experiments.
Criteria for detecting CI from sequence data
Each line was founded by a single genotype and popula-
tions underwent frequent, strong bottlenecks during their
evolutionary trajectories. Under these conditions, CI can
only occur after beneficial mutations arise independently
and increase in frequency enough to survive regular bot-
tlenecks (i.e., at least 0.5–10% under our experimental
conditions). Since we sequenced only a small fraction of
individuals (10) from a very large population (7 × 109),
we examined only 0.00000014% of the population on
average. By this sampling scheme, rare genotypes have a
low probability of being observed. Thus, we concluded
that there was evidence for CI in populations that con-
tained multiple genotypes with at least one novel muta-
tion (i.e., AB versus AC, but not A versus AB; the latter was
considered to be a selective sweep in progress). To be con-
servative in our method of identifying CI, we only consid-BMC Evolutionary Biology 2008, 8:85 http://www.biomedcentral.com/1471-2148/8/85
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ered mutations that showed molecular evolutionary
evidence of being adaptive (criteria described in Table 3
and Discussion).
Growth rate assays
Growth rate for each endpoint population was measured
under the same conditions in which the population was
evolved by previously described methods [24,39]. Five
paired replicate assays of the ancestor and evolved end-
point populations were conducted for each of the nine
lines (45 paired fitness assays). Briefly, phage were incu-
bated with hosts for one hour, isolated by adding chloro-
form to lyse the cells, and separated from hosts by
centrifuging for four minutes at 15 K rpm. Initial and final
population sizes (No and Nt, respectively) were estimated
by titering. Fitness assays for mutants with a single nucle-
otide difference relative to wildtype (i.e., C788T or
C1611T) were conducted in the same manner except that,
rather than using population samples, the genotypes were
isolated from a single plaque and confirmed by genome
sequencing.
Estimates of fitness and selection strength
Our measure of fitness is log2 of the absolute growth rate
(r = Nt/No, where t = 1 hour). This is equivalent to the
number of population doublings per hour, and is denoted
w. Fitness of evolved populations relative to ancestor was
calculated as a ratio of the absolute growth rate of the
evolved population relative to that of the ancestor. This
ratio was log transformed due to the exponential property
of phage growth to yield relative fitness (relW  = log2
[(2r)evo/(2r)anc], which is equivalent to the 1+ s formula
used in population genetics). We use the terminology
'selection coefficient' when referring to the single
mutants, but the calculations were done in the same way
as those for relative fitness. As a measure of selection
strength, we estimated the mean selection coefficient (S)
of mutations from each endpoint population as follows:
[∑(relWk × ni)j]/Nk, where n is the frequency of mutation
i, N is the total number of unique mutations, k denotes
the endpoint population, and j is the summation set from
1 to j. As a second measure of selection strength, we calcu-
lated the proportional contribution of increased fitness to
total fitness measured at the end of the evolution trajec-
tory (relW/wend).
Genome sequencing
Mid- and endpoint populations were serially diluted and
plated on a lawn of sensitive hosts to allow plaque forma-
tion. Ten plaque isolates were arbitrarily selected for
genome sequencing (129 genomes were sequenced in
total). Genome sequencing was carried out as previously
described [27].
Statistical analyses
We analyzed relative fitness and selection strength data
using general linear models (ANOVA and nested ANOVA)
and t-tests in JMP (Version 5.1, SAS Institute Inc., Cary,
NC). We tested whether the number of adaptive muta-
tions was similar between harsh and benign environ-
ments by a Mann-Whitney U-test (StatView 5.0.1, SAS
Institute Inc., Cary, NC). We examined the frequency of
clonal interference by a Fisher Exact Test [51].
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